Outcome and safety of a surveillance biopsy guided personalized immunosuppression program after liver transplantation

Efficacy and Safety of Everolimus With Reduced Tacrolimus in Liver Transplant Recipients

(2020) Sung Gyu Lee et al.   TRANSPLANTATION

Renal disease in the allograft recipient

(2020) Frederik Nevens et al.   Best Practice & Research Clinical Gastroenterology

Time to Conversion to an Everolimus‐Based Regimen: Renal Outcomes in Liver Transplant Recipients From the EVEROLIVER Registry

(2020) Faouzi Saliba et al.   LIVER TRANSPLANTATION

Non-invasive screening for subclinical liver graft injury in adults via donor-specific anti-HLA antibodies

(2020) Anne Höfer et al.   Scientific Reports

Systematic review with meta-analysis: sirolimus- or everolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma

(2019) Sam E. Grigg et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

(2019) François Mach et al.   EUROPEAN HEART JOURNAL

Randomized Sirolimus-based early calcineurin inhibitor reduction in liver transplantation

(2019) Bettina M Buchholz et al.   TRANSPLANTATION

Immunosuppression withdrawal in liver transplant recipients on sirolimus

(2019) Josh Levitsky et al.   HEPATOLOGY

DSA are associated with more graft injury, more fibrosis and upregulation of rejection associated transcripts in subclinical rejection.

(2019) Anne Höfer et al.   TRANSPLANTATION

No Gains in Long-Term Survival After Liver Transplantation Over the Past Three Decades

(2018) Abbas Rana et al.   ANNALS OF SURGERY

Histopathology of 460 liver allografts removed at retransplantation: A shift in disease patterns over 27 years

(2018) Lara Neves Souza et al.   CLINICAL TRANSPLANTATION

Molecular profiling of subclinical inflammatory lesions in long-term surviving adult liver transplant recipients

(2018) María-Carlota Londoño et al.   JOURNAL OF HEPATOLOGY

Longterm Survival and Cost-Effectiveness of Immunosuppression Withdrawal After Liver Transplantation

(2018) Tommaso Maria Manzia et al.   LIVER TRANSPLANTATION

Evidence of Chronic Allograft Injury in Liver Biopsies From Long-term Pediatric Recipients of Liver Transplants

(2018) Sandy Feng et al.   GASTROENTEROLOGY

2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection

(2016) A. J. Demetris et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Five-year histological and serological follow-up of operationally tolerant pediatric liver transplant recipients enrolled in WISP-R

(2016) Sandy Feng et al.   HEPATOLOGY

Preferential accumulation of T helper cells but not cytotoxic T cells characterizes benign subclinical rejection of human liver allografts

(2016) Anna K. Baumann et al.   LIVER TRANSPLANTATION

Role of mTOR inhibitors for the control of viral infection in solid organ transplant recipients

(2016) Julio Pascual et al.   Transplant Infectious Disease

Progressive Fibrosis Is Driven by Genetic Predisposition, Allo-immunity, and Inflammation in Pediatric Liver Transplant Recipients

(2016) S. Varma et al.   EBioMedicine

Everolimus and Early Calcineurin Inhibitor Withdrawal: 3-Year Results From a Randomized Trial in Liver Transplantation

(2014) M. Sterneck et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Safety and performance of liver biopsies in liver transplant recipients

(2014) Tim A. Alten et al.   CLINICAL TRANSPLANTATION

Renal Function at Two Years in Liver Transplant Patients Receiving Everolimus: Results of a Randomized, Multicenter Study

(2013) F. Saliba et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients

(2013) Carlos Benítez et al.   HEPATOLOGY

Renal Comorbidity After Solid Organ and Stem Cell Transplantation

(2012) C. Clajus et al.   AMERICAN JOURNAL OF TRANSPLANTATION

A Randomized, Controlled Study to Assess the Conversion From Calcineurin-Inhibitors to Everolimus After Liver Transplantation-PROTECT

(2012) L. Fischer et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Everolimus With Reduced Tacrolimus Improves Renal Function inDe NovoLiver Transplant Recipients: A Randomized Controlled Trial

(2012) P. De Simone et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Complete Immunosuppression Withdrawal and Subsequent Allograft Function Among Pediatric Recipients of Parental Living Donor Liver Transplants

(2012) Sandy Feng et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR)

(2012) René Adam et al.   JOURNAL OF HEPATOLOGY

Evolution of Causes and Risk Factors for Mortality Post-Liver Transplant: Results of the NIDDK Long-Term Follow-Up Study

(2010) K. D. S. Watt et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis

(2010) Eleonora Patsenker et al.   JOURNAL OF HEPATOLOGY

Late protocol liver biopsies in the liver allograft: A neglected investigation?

(2009) George Mells et al.   LIVER TRANSPLANTATION

Protocol Liver Allograft Biopsies

(2009) George Mells et al.   TRANSPLANTATION

Risk Factors in Patients With Rapid Recurrent Hepatitis C Virus–Related Cirrhosis Within 1 Year After Liver Transplantation

(2009) T. Zimmermann et al.   TRANSPLANTATION PROCEEDINGS